Recent Episodes...
Featured
Interviews...
Featured
Shifting healthcare from reactive to proactive, Dr. Matthew Rabinowitz breaks down how preventive genomic medicine can save $200 billion annually in healthcare costs.
Interviews recorded at BIO’s CEO and Investor Conference with two biotech executives: Cellinfinty Bio’s Dr. Premal Patel and Azitra’s Dr. Travis Whitfill.
The co-founder of ADCY5.org, Gay Grossman, shares about her experience parenting a child with ADCY5-related movement disorder and how patient advocacy organizations are vital in rare disease research.
Interviews...
Shifting healthcare from reactive to proactive, Dr. Matthew Rabinowitz breaks down how preventive genomic medicine can save $200 billion annually in healthcare costs.
Interviews recorded at BIO’s CEO and Investor Conference with two biotech executives: Cellinfinty Bio’s Dr. Premal Patel and Azitra’s Dr. Travis Whitfill.
Dr. Henry Erlich on DNA Evidence, Exonerations, and Ethical Dilemmas.
Dr. Josiah Allen explains how genetic mutations (like RET) influence the safety of GLP-1 agonists like Ozempic and Wegovy.
Two UCD experts, Holly Bernal and Laurie Bernstein, share how clinicians can better engage patients in their own care to help them sustain their daily UCD management needs.
Join Susannah’s father, Luke Rosen, and her physician, Dr. Jennifer Bain, as they share her remarkable progress and hope-filled journey with n-Lorem’s groundbreaking nano-rare treatments.
“It Happened To Me” episode featuring Dr. Robert Bucelli on the role of genetics in diagnosing and treating neuromuscular disorders.
Learn from Dr. Colleen Campbell and Brian Reys how the new code will transform billing for genetic counselors and streamline the service.
Drs. Eric Green and Bruce Gelb join our host Kira Dineen for our annual reflection and recap on the biggest genetics/genomics advancements this year!
Dr. Brian Shirts and Katy Meta explore how cascade genetic testing empowers families to prevent hereditary conditions.